133 related articles for article (PubMed ID: 2455328)
1. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis.
Strandvik B; Brönnegård M; Gilljam H; Carlstedt-Duke J
Scand J Gastroenterol Suppl; 1988; 143():1-4. PubMed ID: 2455328
[TBL] [Abstract][Full Text] [Related]
2. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect.
Carlstedt-Duke J; Brönnegård M; Strandvik B
Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9202-6. PubMed ID: 3097647
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid metabolism in cystic fibrosis.
Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):121-9. PubMed ID: 20673710
[TBL] [Abstract][Full Text] [Related]
4. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis.
Strandvik B
Acta Paediatr Scand Suppl; 1989; 363():58-63; discussion 63-5. PubMed ID: 2701926
[TBL] [Abstract][Full Text] [Related]
5. Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms.
Wheelock CE; Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2020 Sep; 160():102156. PubMed ID: 32750662
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis.
Wood LG; Fitzgerald DA; Garg ML
J Am Coll Nutr; 2003 Aug; 22(4):253-7. PubMed ID: 12897038
[TBL] [Abstract][Full Text] [Related]
7. Generation and metabolism of leukotrienes in granulocytes of patients with cystic fibrosis.
Saak A; Schönfeld W; Knöller J; Steinkamp G; von der Hardt H; König W
Int Arch Allergy Appl Immunol; 1990; 93(2-3):227-36. PubMed ID: 1965982
[TBL] [Abstract][Full Text] [Related]
8. Modulation of adjuvant-induced arthritis by dietary arachidonic acid in essential fatty acid-deficient rats.
Chinn KS; Welsch DJ; Salsgiver WJ; Mehta A; Raz A; Obukowicz MG
Lipids; 1997 Sep; 32(9):979-88. PubMed ID: 9307941
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids suppress the enhanced production of 5-lipoxygenase products from polymorph neutrophil granulocytes in cystic fibrosis.
Keicher U; Koletzko B; Reinhardt D
Eur J Clin Invest; 1995 Dec; 25(12):915-9. PubMed ID: 8719931
[TBL] [Abstract][Full Text] [Related]
11. Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis.
Gilljam H; Strandvik B; Ellin A; Wiman LG
Scand J Clin Lab Invest; 1986 Oct; 46(6):511-8. PubMed ID: 3775237
[TBL] [Abstract][Full Text] [Related]
12. Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosis.
Kopp BT; Thompson R; Kim J; Konstan R; Diaz A; Smith B; Shrestha C; Rogers LK; Hayes D; Tumin D; Woodley FW; Ramilo O; Sanders DB; Groner JA; Mejias A
Thorax; 2019 Mar; 74(3):237-246. PubMed ID: 30661024
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.
Morin C; Cantin AM; Vézina FA; Fortin S
Mar Drugs; 2018 May; 16(6):. PubMed ID: 29861448
[TBL] [Abstract][Full Text] [Related]
14. Absorption and metabolism of [3H]arachidonic and [14C]linoleic acid in essential fatty acid-deficient rats.
Hjelte L; Melin T; Nilsson A; Strandvik B
Am J Physiol; 1990 Jul; 259(1 Pt 1):G116-24. PubMed ID: 2115302
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast fatty acids in cystic fibrosis.
Chase HP; Dabiere CS; Elliott RB
Metabolism; 1980 Apr; 29(4):365-8. PubMed ID: 7374444
[TBL] [Abstract][Full Text] [Related]
16. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis.
Strandvik B; Gronowitz E; Enlund F; Martinsson T; Wahlström J
J Pediatr; 2001 Nov; 139(5):650-5. PubMed ID: 11713441
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles.
Witters P; Dupont L; Vermeulen F; Proesmans M; Cassiman D; Wallemacq P; De Boeck K
J Cyst Fibros; 2013 May; 12(3):222-8. PubMed ID: 23102588
[TBL] [Abstract][Full Text] [Related]
18. Oxygenation products of arachidonic acid: third messengers for insulin release.
Metz SA; Fujimoto WY; Robertson RP
J Allergy Clin Immunol; 1984 Sep; 74(3 Pt 2):391-402. PubMed ID: 6432880
[TBL] [Abstract][Full Text] [Related]
19. Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients.
Van Biervliet S; Vanbillemont G; Van Biervliet JP; Declercq D; Robberecht E; Christophe A
Ann Nutr Metab; 2007; 51(6):541-9. PubMed ID: 18227622
[TBL] [Abstract][Full Text] [Related]
20. Airway nitric oxide in patients with cystic fibrosis is associated with pancreatic function, Pseudomonas infection, and polyunsaturated fatty acids.
Keen C; Olin AC; Edentoft A; Gronowitz E; Strandvik B
Chest; 2007 Jun; 131(6):1857-64. PubMed ID: 17400678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
